3-cycloalkyl-propanamides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514150, 514464, 514522, 549438, 549439, 552 8, 558392, A61K 31275, C07C25531

Patent

active

052409600

ABSTRACT:
A compound selected from the group consisting of all tautomeric forms of a cycloalky-propanamide of the formula ##STR1## wherein R.sub.1 is cycloalkyl of 3 to 6 carbon atoms, R.sub.2 is hydrogen or alkyl of 1 to 3 carbon atoms, R.sub.3, R.sub.4, R.sub.5, R.sub.6 and R.sub.7 are individually selected from the group consisting of hydrogen, halogen, --NO.sub.2, azido, --CN, alkyl, alkoxy and alkylthio of 1 to 6 carbon atoms, --(CH.sub.2).sub.m --CF.sub.3, --O--(CH.sub.2).sub.m --CF.sub.3, --S--(CH.sub.2).sub.m --CF.sub.3, m is an integer from 0 to 3, --CF.sub.2 --Hal, --OCF.sub.2 --Hal, ##STR2## n is an integer from 1 to 3, Hal, Hal.sub.1, Hal.sub.2 and Hal.sub.3 are individually halogen, and --COR', R' is --OH or alkyl or alkoxy of 1 to 3 carbon atoms or R.sub.4 and R.sub.5 together are --O--CH.sub.2 --O-- and their non-toxic, pharmaceutically acceptable basic salts having anti-inflammatory activity.

REFERENCES:
patent: 4946867 (1990-08-01), Manabe et al.
patent: 5034410 (1991-07-01), Sjogren et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3-cycloalkyl-propanamides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-cycloalkyl-propanamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-cycloalkyl-propanamides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2297658

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.